Senator Maria Cantwell Joins Congressional Democrats in Legal Battle to Protect Mifepristone Access
U.S. Senator Maria Cantwell, along with over 250 Senate and House Democrats, has filed an amicus brief to the Fifth Circuit Court of Appeals in the case of Louisiana v. Food and Drug Administration. The case challenges restrictions on mifepristone, an FDA-approved abortion medication. Louisiana seeks to reinstate a nationwide in-person dispensing requirement for mifepristone, which has been deemed safe and effective by the FDA since 2000. The proposed restrictions could end telemedicine access to mifepristone, affecting over 25% of abortion patients who use this method. The case could also impose a nationwide ban on mifepristone prescriptions via telemedicine, impacting over 60% of medication abortions in Washington state. 
